<p>You are about to enter the B. Braun Melsungen AG (global) website. If you are from United States, visit the U. S. Website</p>

United States - B. Braun Medical Inc.

Australia - B. Braun Australia Pty. Ltd

<p>Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.</p>

Cancel

You have successfully logged out.

Oncology

Cancer therapy for oncology patients and health care professionals

Cancer is a complex diagnosis that poses exceptional challenges for patients and medical staff and involves interdisciplinary teams. For oncologists, nurses and pharmacists, cancer treatment has a different focus, but all are committed to improving their patients’ quality of life. By continuously developing smart, innovative solutions and services that simplify and standardise procedures, we contribute to safer therapies. We focus on patients’ needs and involve them into their treatments while protecting health.

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professional before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.

Chemotherapy administration

Protecting health care professionals from exposure to cytotoxic drugs

Administering chemotherapy does not come without risks. B. Braun is committed to delivering a safer work environment.¹Our solutions for drug application in oncology are developed to help protect healthcare workers and patients from contamination with cytostatic agents.

oncology-patient-with-glasses-sitting-on-the-chair-and-nurse-with-gloves-handling-cytoset-in-dayclinic

oncology-patient-with-glasses-sitting-on-the-chair-and-nurse-with-gloves-scanning-patient-identification-on-wristband-for-safety-and-documentation-in-dayclinic

Chemotherapy administration

Chemotherapy administration for patient-centered cancer treatment

Cancer treatment is emotionally and technically taxing and requires medication management that is efficient and works intuitively. B. Braun is committed to delivering a higher patient safety.2

Chemotherapy from preperation to administration

Traceability to drive the focus from drug to patient

Medication management in oncology does not end after the preparation of cytotoxics. It needs an efficient collaboration between the pharmacist, the physician, and the nurse. It also requires traceability along the treatment pathway to identify and to help to avoid medication errors.

oncology-nurse-preparing-and-labeling-cytostatica-for-safe-application-and-pharmacist-documenting-in-software-onco-safety-remote-control

Chemotherapy preparation

Protecting health care professionals during cytotoxic drug preparation

Optimising workflows and using closed-system devices can minimise exposure to hazardous drugs thus contributing to the health and safety of all healthcare workers dealing daily with cytotoxics.

Nutrition in oncology

The prevalence of malnutrition ranges between 20-70% in cancer patients⁵

The clinical consequences of malnutrition in cancer patients can be higher infection rates, more frequent interruptions of treatment, lower quality of life and longer hospital stays.³

Early diagnostics and treatment of malnutrition in cancer patients can lead to improved health-related quality of life.⁴

oncologist-consulting-cancer-patient-and-giving-advice-via-ipad-at-the-table-in-the-consultancy-room-about-adjuvant-nutritional-therapy-and-remune

Efficient preparation and administration

Our safety products for chemotherapy

Cyto-Set^®Mix, Cyto-Set^®Line

Connection system for Cyto-Set^® gravity infusion-, Infusomat^® Space, Infusomat^® Plus sets.

Mini-Spike® Chemo

Dispensing Pins

Easypump® II ST/LT

Elastomeric infusion pump for short- and long-term infusion therapy

Puresite / Closed Male Connector

Transfer device for admixture and IV administration designed to reduce toxic drug exposure.

Ports and needles for vascular access

A vascular access port device consists of a catheter connected to a reservoir. It is implanted subcutaneously and namely used to deliver drugs into the blood stream.

Holistic chemotherapy treatment

In addition to a broad product portfolio, B. Braun partners with oncology departments to implement solutions for enhanced cancer treatment and edication management.

Managing medication in oncology

Get in touch with our experts

Oncology

Thank you for sending us your email.

Salutation

Ms. Mr. Mx.

First Name *

Last Name *

Country *

Company/Hospital

Business e-Mail *

Phone *

Your Request *

Marketing Permission

Yes, I would like to receive additional information about relevant therapies, products, solutions or events from B. Braun and its contracted distribution partners in future.

B. Braun Australia is the responsible organisation

The protection of the personal data of our customers is very important to us and we take it very seriously. Your personal data is subject to data protection and the collection and storage is subject to Australia Privacy Laws and our Privacy Policy. Under no circumstances will we pass on your personal data to third parties outside of the B. Braun Group or use or store them for any other purposes. Our staff has been trained to handle personal data and is obliged to comply with the data protection regulations.

Data Protection *

I have read the data protection policy and agree with processing of my personal data according to the data protection policy. I can cancel this approval at any time.

[1] Application study: Conventional infusion devices versus closed system (Cyto-Set®) – risk-reduced and effective preparation and application of chemotherapy. L. Gubelt (KEM I Evang. Kliniken Essen-Mitte gGmbH).

[2] ONCOSAFETY REMOTE CONTROL®: PATIENT SAFETY AND TREATMENT TRACEABILITY Callado Fortes, S.; Madrid Garzón, D.; Crespo García, I.; Sánchez Molano, M. B.; Martínez García, I.; Lejarcegui Urquiza, U.; Olea Etxebarrieta, L.; Meskaoui Samir, W.; Guinea Vitorica, O.; Espina

Grisaleña, M. B.; Sánchez Tremiño, P.; Barayazarra Echaniz, M.; Echevarria San Martín, S.; Onaindia Arrizabalaga, G.; Montero Matia, R.; Teijeiro Pulido, M. J. Day Hospital - Hospital Galdakao-Usansolo | OSI Barrualde-Galdakao (OSAKIDETZA).

[3] Santarpia, Lidia, Franco Contaldo, and Fabrizio Pasanisi. Nutritional screening and early treatment of malnutrition in cancer patients. Journal of cachexia, sarcopenia and muscle 2.1 (2011): 27-35.

[4] Trabal, Joan, et al. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutricion hospitalaria 25.5 (2010): 736-740.

[5] Beirer, A. Malnutrition and cancer, diagnosis and treatment. memo 14, 168-173 (2021)

Stay connected with My B. Braun